Shares of Relx Plc (NYSE:RELX – Get Free Report) have been given a consensus recommendation of “Buy” by the eight brokerages that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and two have given a strong buy recommendation to the company.
A number of research firms have recently weighed in on RELX. Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a report on Monday, February 2nd. Deutsche Bank Aktiengesellschaft upgraded shares of Relx from a “hold” rating to a “buy” rating in a research report on Tuesday, December 9th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Relx in a research report on Monday, December 29th. Zacks Research raised shares of Relx from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 6th. Finally, Wall Street Zen raised shares of Relx from a “hold” rating to a “buy” rating in a research note on Saturday.
View Our Latest Research Report on Relx
Institutional Investors Weigh In On Relx
Relx Trading Down 0.6%
Shares of RELX opened at $29.31 on Wednesday. The stock has a 50 day moving average of $39.16 and a 200-day moving average of $43.45. The company has a current ratio of 0.47, a quick ratio of 0.42 and a debt-to-equity ratio of 2.55. Relx has a 52 week low of $29.09 and a 52 week high of $56.33.
Relx Company Profile
RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.
RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.
Featured Articles
- Five stocks we like better than Relx
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.
